Recruiting NA INTERVENTIONAL 2-arm NCT06088212

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor (Cog-HF)

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor: the Cog-HF Trial

Sponsor: Baker Heart and Diabetes Institute

Conditions Cognitive Change Cognitive Decline Cognitive Impairment Dementia Heart Failure Left Ventricular Dysfunction

Interventions Disease management program

Updated 4 times since 2023 Last updated: Aug 9, 2024 Started: Jul 1, 2024 Primary completion: Oct 31, 2025 Completion: Jul 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cognitive Change and Cognitive Decline and is currently actively recruiting participants. Baker Heart and Diabetes Institute leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Dec 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA
Nov 2023 — Dec 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart and Diabetes Institute

Data source: Baker Heart and Diabetes Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hobart, Australia